Results 71 to 80 of about 84,870 (207)
Multi‐omics analyses reveal host–microbe interactions in atopic dermatitis and psoriasis
Journal of the European Academy of Dermatology and Venereology, EarlyView.Atopic dermatitis (AD) and psoriasis (PSO) are chronic inflammatory skin diseases with complex host–microbe interactions. This study analysed skin samples from patients and healthy individuals using integrated microbial and transcriptomic profiling. Both diseases showed disrupted fungal–bacterial interactions and alterations in host immune responses ...
Ying Yang +8 more
wiley +1 more source
Anais brasileiros de dermatologia, 2012 Seborrheic dermatitis is a chronic relapsing erythematous scaly skin disease, the prevalence of which is around 1 to 3% of the general population in the United States. It has two incidence peaks, the first in the first three months of life and the second beginning at puberty and reaching its apex at 40 to 60 years of age.
Ana Luisa Sobral Bittencourt, Sampaio +5 more
openaire +2 more sources
HEALTH CARE OF PATIENTS WITH SEBORRHEIC DERMATITIS [PDF]
, 2015 Seborojični dermatitis je čest problem nepoznate etiologije. Oko 3 do 5% odraslih ima seborojični dermatitis. Pojam proizlazi iz nastanka ovog poremećaja, u kojem se eritematozne, ljuskaste mrlje razvijaju u područjima koja su bogata sebacealnim ...
Dovranić, Zrinka
core +3 more sources
Setmelanotide in Bardet‐Biedl Syndrome: A Case Report
Pediatric Dermatology, EarlyView.ABSTRACT Setmelanotide is a melanocortin‐4‐receptor agonist used for the treatment of hyperphagia in the genetic obesity syndrome Bardet‐Biedl. Presented is a case of diffuse hyperpigmentation in a patient treated with setmelanotide, which represents the most common side effect of this medication.
Shelby Smith +2 more
wiley +1 more source
International Journal of Pediatric Health Care & Advancements, 2015 Seborrheic dermatitis is a common chronic inflammatory skin disease characterized by erythema and greasy scales affecting areas rich in sebaceous glands. Seborrheic dermatitis has two incidence peaks, the first in the first three months of life and the second beginning at puberty, reaching its apex at 30 to 40 years of age.
Peter A. Lio +3 more
openaire +2 more sources
Pediatric Dermatology, EarlyView.ABSTRACT Although topical corticosteroids are known triggers in the development of perioral dermatitis (PD), investigation into inhalant and nasal corticosteroid preparations, commonly used to manage allergic rhinitis and asthma, remains limited to case series.
Taylor Merkle +4 more
wiley +1 more source
Pediatric Dermatology, EarlyView.ABSTRACT Langerhans cell histiocytosis (LCH) is a neoplastic process originating from immature myeloid precursor cells. In this report, we describe a case of a 17‐month‐old with scaling of the scalp and swelling of the bilateral parotid glands who developed acute respiratory distress.
Aretha On +4 more
wiley +1 more source
MicrobiologyOpen, Volume 15, Issue 5, October 2026.Malassezia (predominantly M. globosa) colonizes BCC tissues. In vitro fungal stimulation accelerates epithelial proliferation and modulates inflammatory/oxidative stress cascades potentially relevant to BCC biology. ABSTRACT Basal cell carcinoma (BCC) is the most common malignant skin tumor.
Xiaolei Zhu +5 more
wiley +1 more source
PDE4 Inhibition in Dermatologic Disease: Impacts Beyond Inflammation
International Journal of Dermatology, Volume 65, Issue 10, Page 2038-2048, October 2026.This graphical abstract demonstrates the comprehensive mechanism of PDE4 inhibition in skin physiology. By increasing intracellular cAMP and activating PKA, PDE4 inhibitors exert pleiotropic effects, including immune modulation, pigmentation regulation, barrier enhancement, sensory neuron modulation, and improved wound healing with reduced fibrosis ...
Keana Khodadad +2 more
wiley +1 more source
Dermatological Disease at a Tertiary Military Hospital in Burundi: A Retrospective Review
International Journal of Dermatology, EarlyView.
Doriane Sabushimike +5 more
wiley +1 more source